It seems like U.S healthcare is more concerned about profits than patients these days. Now is the time to learn more about the latest legal battles patients face with conditions from head to toe and how to be your own best healthcare advocate, so you receive the care you deserve.
Tepezza is a new prescription infusion medication that gives those suffering from thyroid eye disease hope for a better treatment option. Approved by the FDA on January 21, 2020, Tepezza (brand name for the drug teprotumumab) is the first of its kind to treat thyroid…
Childers, Schlueter & Smith has filed the first lawsuit in Georgia against the manufacturers of Tepezza, the first FDA-approved thyroid eye disease (TED) drug. The monoclonal antibody medication was heralded for its potential to relieve people suffering from the rare condition when it was released…
Over 100 cases against the Paragard IUD (Intrauterine device) manufacturers have been consolidated into a multidistrict litigation (MDL) in the Northern District of Georgia since December 2020. What does this mean for women who have been injured by a Paragard IUD? The Paragard IUD is…
The Paragard IUD is one of the greatest advances in women’s health history. It allows users the peace of mind that comes along with a constant form of birth control, without having to worry about taking a pill, changing a patch, or going in for…
Intrauterine devices, commonly known as IUDs, are a highly effective form of birth control, with more than a 99% success rate. IUDs are inserted at the base of the uterus and held in place by an arm on each side. They work by releasing either…
When it comes to medications, it’s important to remember that there can be risks associated with taking them. And, some of the risks can be serious and even life-threatening. For example, Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), severe conditions affecting the skin and…
Stevens-Johnson Syndrome (“SJS”) and Toxic Epidermal Necrolysis (“TEN”) are among the most lethal and severe adverse cutaneous reactions, and, yet, very little is known to most people about these conditions. Even worse, medical professionals often mismanage the simple treatment of SJS/TEN and pharmaceutical companies deny…
It has been six months since the Food and Drug Administration (FDA) ordered retailers to stop selling all prescription and over-the-counter (OTC) ranitidine medications, commonly known as Zantac. Taking Zantac (Ranitidine) to treat a simple condition such as heartburn, unfortunately, has led to more severe…
After a thorough investigation, the U.S. Food and Drug Administration (FDA) has requested that manufacturers immediately withdraw all prescription and over-the-counter (OTC) ranitidine medications, commonly known by the brand name Zantac, from the market. The FDA has taken this drastic and unusual step due to…
Promising weight-loss drug Belviq has been pulled off the U.S. market due to the potential risk of cancer. At the request of the U.S. Food and Drug Administration (FDA), drug manufacturer Eisai Inc. has voluntarily withdrawn and discontinued sales of Belviq (lorcaserin). The FDA took…
@thumbnail.jpg "M. Brandon Smith")
